Sacral Nerve Stimulation Market Scope
Sacral nerve stimulation therapy is one of several treatment options for the symptoms of overactive bladder. Sacral nerve stimulation therapy can be used to treat overactive bladder with or without urine leakage and also bladder-emptying problems. It is a reversible treatment that uses a small device to send electrical impulses to nerves located in the lower back. These nerves called the sacral nerves, alter muscles and organs that contribute to bladder control. The electrical stimulation can often successfully eliminate or reduce certain bladder-control problems in some people.
The Sacral Nerve Stimulation market study is segmented by Type (Implantable and External), by Application (Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Sacral Nerve Stimulation market throughout the predicted period.
Medtronic (United States), Axonics Modulation Technologies (United States), Nuvectra Corporation (United States), Cogentix Medical (United States), Boston Scientific (United States), St. Jude Medical Inc. (United States), Neuropace Inc. (United States) and Nevro Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Synapse Biomedical Inc. (United States) and Laborie, Inc (Canada).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Sacral Nerve Stimulation market by Type, Application and Region.
On the basis of geography, the market of Sacral Nerve Stimulation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In Oct 2020, Soin Neuroscience Inc. (SNI) has developed a novel implantable sacral nerve stimulator to treat bladder incontinence. As many as 46 million Americans 40 years of age or older have reported symptoms of urinary incontinence often due to a condition known as overactive bladder, according to the American Urological Association., and In Aug 2020, Medtronic plc announced that it's recently FDA-approved InterStim™ Micro neurostimulator for sacral neuromodulation (SNM) therapy is now available in the United States. Cleveland Clinic performed the first patient implant in the nation with the new device.
- Availability of Electrical Stimulators
- Increasing Cases of Urge Incontinence, such as Urinary Tract Infection (UTI)
- Rising Number of Patients Suffering from Overactive Bladder (OAB) and Fecal Incontinence
- Increase In Research and Development Investments
- Increasing Chronic Pain among the Individuals
- Growing Demand from Emerging Market
- Stringent Regulation for Device Approval
- Lack of Knowledge on the Occurrence and Management of Suboptimal Therapeutic Effects
- Intense Competition among Competitor
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Sacral Nerve Stimulation Device Manufacturer, Sacral Nerve Stimulation Devices Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase